SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS REDUCE BOWEL ISCHEMIA-INDUCED LUNG PERMEABILITY AND NEUTROPHIL SEQUESTRATION

被引:63
作者
SORKINE, P
SETTON, A
HALPERN, P
MILLER, A
RUDICK, V
MARMOR, S
KLAUSNER, JM
GOLDMAN, G
机构
[1] ICHILOV HOSP,TEL AVIV MED CTR,DEPT SURG B,IL-64239 TEL AVIV,ISRAEL
[2] ICHILOV HOSP,TEL AVIV MED CTR,DEPT PATHOL,IL-64239 TEL AVIV,ISRAEL
[3] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
[4] CARMEL HOSP,DEPT NEUROL,HAIFA,ISRAEL
关键词
ISCHEMIA; REPERFUSION; LUNGS; ADULT RESPIRATORY DISTRESS SYNDROME; TUMOR NECROSIS FACTOR; RECEPTORS; ANTIBODIES; BACTERIA; CRITICAL ILLNESS; CYTOKINES;
D O I
10.1097/00003246-199508000-00011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To evaluate the possible role of tumor necrosis factor (TNF) in the development of lung injury after bowel ischemia, and the ability of TNF-soluble receptors to negate TNF toxicity, using a rat small bowel ischemia and reperfusion model. Design: Prospective, randomized, controlled laboratory study. Setting: Research laboratory. Subjects: Forty adult male Sprague-Dawley rats weighing similar to 300 g. Interventions: The rats were divided equally into four groups: a) ischemia and reperfusion alone; b) those animals receiving TNF antibodies (1 mL) before reperfusion; and c) those animals receiving 200 mu g of human recombinant TNF soluble receptors, These 30 anesthetized rats underwent 60 mins of superior mesenteric artery occlusion per 4 hrs of reperfusion. The remaining ten animals were sham operated (laparotomy), serving as controls. Lung permeability was measured using bovine serum albumin labeled with I-125, and organ injury was assessed histologically. Measurements and Main Results: Thirty and 60 mins after declamping and reperfusion, plasma TNF concentrations increased to 830 +/- 66 and 173 +/- 56 pg/mL, respectively, compared with 10 pg/mL before ischemia (p < .001). In sham-operated control rats, TNF concentrations did not increase from baseline concentrations. Four hours after reperfusion, sequestration of neutrophils in the pulmonary microcirculation was noted (319 +/- 60 vs, 84 +/- 13 neutrophils/10 high-power fields in sham-operated rats [p < .04]). Pulmonary microvascular leak also occurred, as measured by translocation of radiolabeled albumin into the bronchoalveolar space and expressed as the ratio of bronchoalveolar lavage to blood concentrations. This ratio was 5.3 +/- 0.8 in ischemic control animals compared with 1.1 +/- 0.3 in sham animals (p < .03). Treatment with antibodies to TNF before reperfusion attenuated the pulmonary injury (75 +/- 6 neutrophils/10 high-power fields, permeability index 1.6 +/- 0.1) less than in ischemic controls (p < .005). A similar protection was achieved with soluble TNF receptors, which prevented bowel ischemia-induced lung neutrophil sequestration (117 +/- 35 neutrophils/10 high-power fields, pulmonary vascular leak ratio of 2.3 +/- 0.1, p < .05). Conclusions: The results of this study show that ischemia and subsequent reperfusion of the intestine in rats produce lung injury. This injury is mediated, at least in part, by TNF. Soluble TNF receptors are an effective tool in preventing lung TNF injury after intestinal ischemia.
引用
收藏
页码:1377 / 1381
页数:5
相关论文
共 18 条
[1]   INVOLVEMENT OF NEUTROPHILS IN ISCHEMIA-REPERFUSION INJURY IN THE SMALL-INTESTINE [J].
ARNDT, H ;
KUBES, P ;
GRANGER, DN .
KLINISCHE WOCHENSCHRIFT, 1991, 69 (21-23) :1056-1060
[2]  
BEUTLER B, 1987, CLIN RES, V35, P192
[3]   TUMOR NECROSIS FACTOR/CACHECTIN STIMULATES PERITONEAL-MACROPHAGES, POLYMORPHONUCLEAR NEUTROPHILS, AND VASCULAR ENDOTHELIAL-CELLS TO SYNTHESIZE AND RELEASE PLATELET-ACTIVATING-FACTOR [J].
CAMUSSI, G ;
BUSSOLINO, F ;
SALVIDIO, G ;
BAGLIONI, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1390-1404
[4]   ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN THE PATHOPHYSIOLOGIC ALTERATIONS AFTER HEPATIC ISCHEMIA REPERFUSION INJURY IN THE RAT [J].
COLLETTI, LM ;
REMICK, DG ;
BURTCH, GD ;
KUNKEL, SL ;
STRIETER, RM ;
CAMPBELL, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1936-1943
[5]   ANTICYTOKINE STRATEGIES IN THE TREATMENT OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME [J].
DINARELLO, CA ;
GELFAND, JA ;
WOLFF, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (14) :1829-1835
[6]  
ENGELMANN H, 1989, J BIOL CHEM, V264, P11974
[7]  
HILL J, 1992, SURGERY, V112, P166
[8]   A CD18 ANTIBODY PREVENTS LUNG INJURY BUT NOT HYPOTENSION AFTER INTESTINAL ISCHEMIA-REPERFUSION [J].
HILL, J ;
LINDSAY, T ;
VALERI, CR ;
SHEPRO, D ;
HECHTMAN, HB .
JOURNAL OF APPLIED PHYSIOLOGY, 1993, 74 (02) :659-664
[9]  
LUSCINSKAS FW, 1989, J IMMUNOL, V142, P2257
[10]  
MOHLER KM, 1993, J IMMUNOL, V151, P1548